0001213900-21-054992.txt : 20211028 0001213900-21-054992.hdr.sgml : 20211028 20211028112954 ACCESSION NUMBER: 0001213900-21-054992 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211028 DATE AS OF CHANGE: 20211028 EFFECTIVENESS DATE: 20211028 FILER: COMPANY DATA: COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001728328 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-418909 FILM NUMBER: 211356136 BUSINESS ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 BUSINESS PHONE: (604) 669-7207 MAIL ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 D 1 primary_doc.xml X0708 D LIVE 0001728328 InMed Pharmaceuticals Inc. 815 W. HASTINGS STREET SUITE 310 VANCOUVER A1 BRITISH COLUMBIA, CANADA V6C 1B4 (604) 669-7207 BRITISH COLUMBIA, CANADA None None Corporation true Eric A. Adams 815 W. Hastings Street Suite 310 Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1B4 Executive Officer Director Bruce S. Colwill 815 W. Hastings Street Suite 310 Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1B4 Executive Officer Alexandra D.J. Mancini 815 W. Hastings Street Suite 310 Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1B4 Executive Officer Eric C. Hsu 815 W. Hastings Street Suite 310 Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1B4 Executive Officer Michael Woudenberg 815 W. Hastings Street Suite 310 Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1B4 Executive Officer William J. Garner 815 W. Hastings Street Suite 310 Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1B4 Director Catherine A. Sazdanoff 815 W. Hastings Street Suite 310 Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1B4 Director Adam Cutler 815 W. Hastings Street Suite 310 Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1B4 Director Andrew Hull 815 W. Hastings Street Suite 310 Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1B4 Director Pharmaceuticals Decline to Disclose 06b false 2021-10-13 false true true Offering made to prior stockholders of BayMedica, Inc., as part of the merger consideration. 0 4305000 4305000 0 Offering made to prior stockholders of BayMedica, Inc., as part of the merger consideration. Total amount sold based on a per share price of $2.10. true 2 54 0 0 0 false InMed Pharmaceuticals Inc. /s/ Bruce S. Colwill Bruce S. Colwill Chief Financial Officer 2021-10-28